Clearmind Announces Positive Safety Findings for CMND 100 , Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA - Regulated Clinical Trial

Covered by 1 of 117 currently active countries' press · not covered by: United Arab Emirates, Afghanistan, Algeria, Azerbaijan, Albania, Armenia, Angola, Argentina, Australia, Austria, Bahrain, Belgium…

• manilatimes.net Clearmind Announces Positive Safety Findings for CMND 100 , Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA - Regulated Clinical Trial